Journal CME - 2018 January
Back to Journal CME - 2018 January
Journal CME - 2018 January

Journal CME - 2018 January

Summary:

Background: When a muscle relaxant is administered to facilitate intubation, the benefits of anticholinesterase reversal must be balanced with potential risks. The aim of this double-blinded, randomized noninferiority trial was to evaluate the effect of neostigmine administration on neuromuscular function when given to patients after spontaneous recovery to a train-of-four ratio of 0.9 or greater.
Methods: A total of 120 patients presenting for surgery requiring intubation were given a small dose of rocuronium. At the conclusion of surgery, 90 patients achieving a train-of-four ratio of 0.9 or greater were randomized to receive either neostigmine 40 µg/kg or saline (control). Train-of-four ratios were measured from the time of reversal until postanesthesia care unit admission. Patients were monitored for postextubation adverse respiratory events and assessed for muscle strength.
Results: Ninety patients achieved a train-of-four ratio of 0.9 or greater at the time of reversal. Mean train-of-four ratios in the control and neostigmine groups before reversal (1.02 vs. 1.03), 5 min postreversal (1.05 vs. 1.07), and at postanesthesia care unit admission (1.06 vs. 1.08) did not differ. The mean difference and corresponding 95% CI of the latter were -0.018 and -0.046 to 0.010. The incidences of postoperative hypoxemic events and episodes of airway obstruction were similar for the groups. The number of patients with postoperative signs and symptoms of muscle weakness did not differ between groups (except for double vision: 13 in the control group and 2 in the neostigmine group; P = 0.001).
Conclusions: Administration of neostigmine at neuromuscular recovery was not associated with clinical evidence of anticholinesterase-induced muscle weakness.

CME Credit: 1.00 AMA PRA Category 1 Credit

Required Hardware / Software:
Adobe Acrobat Reader, Internet connection. Web browser version must have been released within the last three years.

Activity Release Date:
12/12/2017

Activity Expiration Date:
12/11/2020

  • List Price: $20.00
  • Member Price: Free
 
Want to save more?
Log into see if you qualify for a lower rate.
Members save $20.00 or more Join
Item Details:

Learning Objectives: After successfully completing this activity, the learner will be able to:

  • Determine when a patient has complete neuromuscular blockade reversal, defined as a train-of-four (TOF) ratio of 0.9 or greater (1, 3)
  • Recognize signs and symptoms of inadequate neuromuscular...
Back to Journal CME - 2018 January
View More View Less
Back to Product Detail
There are not any reviews for this product.

Thank You Industry Supporters

Whose contributions allow the American Society of Anesthesiologists® to create world-class education and resources to improve patient care and outcomes.

Learn More